Figure S6 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance

Figure S6 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance

<p>Original picture</p>

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Xiaodong Shu (16721586) (author)
Andere auteurs:	Jianjie Li (16721589) (author), Un In Chan (16721592) (author), Sek Man Su (16721595) (author), Changxiang Shi (16721598) (author), Xin Zhang (16721601) (author), Tingting An (16721604) (author), Jun Xu (16721607) (author), Lihua Mo (16721610) (author), Jianlin Liu (16721613) (author), Yuqing Wang (16721616) (author), Xiaoling Li (16721619) (author), Min Deng (16721622) (author), Josh Haipeng Lei (16721625) (author), Chunfei Wang (16721628) (author), Hao Tian (16721631) (author), Sun Heng (16721634) (author), Joong Sup Shim (16721637) (author), Xuanjun Zhang (16721640) (author), Yunlu Dai (16721643) (author), Zhicheng Yao (16721646) (author), Xiaying Kuang (16721649) (author), Ying Lin (15293140) (author), Chu-Xia Deng (16721652) (author), Xiaoling Xu (16721655) (author)
Gepubliceerd in:	2025
Onderwerpen:	Cancer Cancer Biology Tumor Biology Immuno-oncology Breast Cancer Immunology Immunotherapy Checkpoint blockade Oncogenes & Tumor Suppressors Progression, Invasion & Metastasis Tumor Microenvironment
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Figure S1 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
door: Xiaodong Shu (16721586)
Gepubliceerd in: (2025)

Figure S2 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
door: Xiaodong Shu (16721586)
Gepubliceerd in: (2025)

Figure S3 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
door: Xiaodong Shu (16721586)
Gepubliceerd in: (2025)

Figure S4 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
door: Xiaodong Shu (16721586)
Gepubliceerd in: (2025)

Figure S5 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
door: Xiaodong Shu (16721586)
Gepubliceerd in: (2025)

Figure S7 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
door: Xiaodong Shu (16721586)
Gepubliceerd in: (2025)

Table S1-S9 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
door: Xiaodong Shu (16721586)
Gepubliceerd in: (2025)

Supplementary Table S1 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
door: Christine Pich-Bavastro (16509238)
Gepubliceerd in: (2025)

Supplementary Table S2 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
door: Christine Pich-Bavastro (16509238)
Gepubliceerd in: (2025)

Supplementary Table S3 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
door: Christine Pich-Bavastro (16509238)
Gepubliceerd in: (2025)

Supplementary Table S4 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
door: Christine Pich-Bavastro (16509238)
Gepubliceerd in: (2025)

Supplementary Table S5 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
door: Christine Pich-Bavastro (16509238)
Gepubliceerd in: (2025)

Supplementary Table S6 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
door: Christine Pich-Bavastro (16509238)
Gepubliceerd in: (2025)

Supplementary Table S7 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
door: Christine Pich-Bavastro (16509238)
Gepubliceerd in: (2025)

Supplementary Data from Attenuation of Sialylation Augments Antitumor Immunity and Improves Response to Immunotherapy in Ovarian Cancer
door: Kankan Cao (16437263)
Gepubliceerd in: (2025)

Table S8 from Immunologic Predictors for Clinical Responses during Immune Checkpoint Blockade in Patients with Myelodysplastic Syndromes
door: Sung-Eun Lee (14855067)
Gepubliceerd in: (2025)

Supplementary Table S1 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
door: Aleksandar Obradovic (7549517)
Gepubliceerd in: (2025)

Supplementary Table S2 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
door: Aleksandar Obradovic (7549517)
Gepubliceerd in: (2025)

Table S1-S8 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
door: Ruiyun Zhang (17142498)
Gepubliceerd in: (2025)

Figure 1 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
door: Clare Vesely (505402)
Gepubliceerd in: (2025)

Figure 2 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
door: Clare Vesely (505402)
Gepubliceerd in: (2025)

Figure 3 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
door: Clare Vesely (505402)
Gepubliceerd in: (2025)

Figure 4 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
door: Clare Vesely (505402)
Gepubliceerd in: (2025)

Figure 5 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
door: Clare Vesely (505402)
Gepubliceerd in: (2025)

Table 1 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
door: Clare Vesely (505402)
Gepubliceerd in: (2025)

Supplementary Figures from NKG7 Is Required for Optimal Antitumor T-cell Immunity
door: Xian-Yang Li (15022958)
Gepubliceerd in: (2025)

Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
door: Arianna Draghi (15126339)
Gepubliceerd in: (2025)

Supplementary Data 2 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
door: Arianna Draghi (15126339)
Gepubliceerd in: (2025)

Supplementary Data 3 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
door: Arianna Draghi (15126339)
Gepubliceerd in: (2025)

Supplementary Tables from MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages
door: Renumathy Dhanasekaran (14962092)
Gepubliceerd in: (2025)

Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
door: Sonia A. Patel (15055688)
Gepubliceerd in: (2025)

Supplementary Figure S2 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
door: Sonia A. Patel (15055688)
Gepubliceerd in: (2025)

Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
door: Sonia A. Patel (15055688)
Gepubliceerd in: (2025)

Supplementary Figure S4 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
door: Sonia A. Patel (15055688)
Gepubliceerd in: (2025)

Supplementary Figure S5 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
door: Sonia A. Patel (15055688)
Gepubliceerd in: (2025)

Supplementary video 1 from Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy
door: Alvaro Teijeira (14962650)
Gepubliceerd in: (2025)

Supplementary video 2 from Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy
door: Alvaro Teijeira (14962650)
Gepubliceerd in: (2025)

Supplementary video 3 from Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy
door: Alvaro Teijeira (14962650)
Gepubliceerd in: (2025)

Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
door: Hansol Lee (15054787)
Gepubliceerd in: (2025)

Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
door: Hansol Lee (15054787)
Gepubliceerd in: (2025)

Cannot write session to /tmp/vufind_sessions/sess_ivnjuuk5al75lrds85q9rp1egh